Skip to main content

Table 1 Relevant clinical and pathological data

From: Expression of fibrillin-1 in focal nodular hyperplasia of the liver: a role in microcirculation adaptability

Patient

Age/Sex (years)

Tumor

Non-tumoral Liver

  

Pathology

Size (cm)

 

1

30/F

FNH

5

N

2

15/F

FNH

7.6

N

3

37/F

FNH

2.5

N

4

36/F

FNH

8

N

5

34/F

FNH

7

N

6

41/F

FNH

5.3

N

7

54/F

FNH

7

N

8

14/F

FNH

6

N

9

44/F

FNH

10

N

10

32/F

FNH

7

N

11

35/F

FNH

5.5

N

12

48/F

FNH

8

N

13

32/F

FNH

8

N

14

38/F

FNH

7

Steatosis é Peliosis

15

38/F

FNH

11

N

16

50/F

FNH

2.5

Steatosis

17

44/F

FNH T

7

N

18

39/F

FNH T

3

N

19

34/F

FNH T

8

Steatosis

20

40/F

FNH HCA

2.5 3

Peliosis

21

28/F

FNH HCA

1 4

N

22

38/F

FNH HCA

13 4

N

23

28/F

HCA

8

Steatosis

24

43/M

HCA

3.5

Steatosis

25

43/F

HCA

13

N

26

34/F

HCA

6

N

27

45/F

HCA

10

Peliosis

28

14/M

HCA

2.7

N

29

50/F

HCA

11

Peliosis

30

39/F

HCA

7

N

31

30/F

HCA

10

N

32

49/M

HCA

-

N

33

52/F

HCA

5

N

34

46/F

HCA

11

N

  1. FNH: Focal nodular hyperplasia, FNH T: Telangiectatic focal nodular hyperplasia, HCA: Hepatocellular adenoma, N: Normal